Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Nyxoah SA brings in €15mm in third financing round

Executive Summary

Nyxoah SA (developing a hypoglossal nerve stimulation therapy for obstructive sleep apnea) raised €15mm ($17.1mm) in its third financing round, which was led by Cochlear Ltd. (adds a board member) and returning shareholders. The company will use the funds to commence post-CE Mark European market development activities and work towards IDE with the FDA.
Deal Industry
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies